Pfizer
PFE
PFE
2,920 hedge funds and large institutions have $95.1B invested in Pfizer in 2025 Q1 according to their latest regulatory filings, with 178 funds opening new positions, 1,277 increasing their positions, 1,197 reducing their positions, and 190 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
1.51% less ownership
Funds ownership: 66.17% → 64.66% (-1.5%)
2% less funds holding
Funds holding: 2,985 → 2,920 (-65)
23% less call options, than puts
Call options by funds: $2.98B | Put options by funds: $3.87B
Holders
2,920
Holding in Top 10
44
Calls
$2.98B
Puts
$3.87B
Top Buyers
| 1 | +$950M | |
| 2 | +$587M | |
| 3 | +$470M | |
| 4 |
Amundi
Paris,
France
|
+$412M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$342M |
Top Sellers
| 1 | -$2.81B | |
| 2 | -$955M | |
| 3 | -$429M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$261M |
| 5 |
Two Sigma Advisers
New York
|
-$239M |